Mod Pathol 1999, 12: 69–74.PubMed 9. Shigeishi H, Mizuta K, Higashikawa K, Yoneda S, Ono S, Kamata N: Correlation of CENP-F gene expression with tumor-proliferating activity in human salivary gland tumors. Oral Oncol 2005, 41: 716–722.CrossRefPubMed 10. Sugata N, Munekata E, Todokoro K: Characterization of a novel kinetochore protein, CENP-H. J Biol Chem 1999, 274: 27343–27346.CrossRefPubMed 11. Fukagawa T, Mikami Y, Nishihashi A, Regnier V, Haraguchi T, Hiraoka Y, Sugata N, Todokoro K, Brown W, Ikemura T: CENP-H, a constitutive centromere component, is required for centromere targeting of CENP-C
in vertebrate cells. Embo J 2001, 20: 4603–4617.CrossRefPubMed 12. Sugata N, Li S, Earnshaw WC, Yen TJ, Yoda Autophagy inhibitor in vivo K, Masumoto H, Munekata E, Warburton PE, Todokoro K: Human CENP-H multimers colocalize with CENP-A and
CENP-C at active centromere – kinetochore complexes. Hum Mol Genet 2000, 9: 2919–2926.CrossRefPubMed 13. Cheeseman IM, Hori T, Fukagawa T, Desai A: KNL1 and the CENP-H/I/K Complex Coordinately Direct Kinetochore Assembly in Vertebrates. Mol Biol Cell 2008, 19: 587–594.CrossRefPubMed 14. Hori T, Okada M, Maenaka K, Fukagawa T: CENP-O class proteins form a stable complex and are required for proper kinetochore www.selleckchem.com/products/abc294640.html function. Mol Biol Cell 2008, 19: 843–854.CrossRefPubMed 15. Liao WT, Song LB, Zhang HZ, Zhang X, Zhang L, Liu WL, Feng Y, Guo BH, Mai HQ, Cao SM, Li MZ, Qin HD, Zeng YX, Zeng MS: Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival. Clin Cancer Res 2007, 13: 508–514.CrossRefPubMed 16. Guo XZ, Zhang G, Wang JY, Liu WL, Wang F, Dong JQ, Xu LH, Cao JY, Hormones antagonist Song LB, Zeng MS: Prognostic relevance of Centromere protein H expression in esophageal carcinoma. BMC Cancer 2008, 8: 233.CrossRefPubMed 17. Shigeishi H, Higashikawa K, Ono S, Mizuta K, Ninomiya Y, Yoneda S, Taki M, Kamata N: Increased expression of CENP-H gene in human oral squamous cell carcinomas harboring high-proliferative activity. Oncol Rep 2006, 16: 1071–1075.PubMed 18. Reshmi SC, Gollin
SM: Chromosomal instability in oral cancer cells. J Dent Res 2005, 84: 107–117.CrossRefPubMed 19. Greenberg JS, Fowler R, Gomez J, Mo V, Roberts D, El Naggar AK, Myers JN: Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer 2003, 97: 1464–1470.CrossRefPubMed 20. Haddadin KJ, Soutar DS, Webster MH, Robertson AG, Oliver RJ, MacDonald DG: Natural history and patterns of recurrence of tongue tumours. Br J Plast Surg 2000, 53: 279–285.CrossRefPubMed 21. Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, Shao JY, Wu QL, Li MZ, Xia YF, Fu LW, Huang WL, Dimri GP, Band V, Zeng YX: Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 2006, 66: 6225–6232.CrossRefPubMed 22.